Development of a hospital-based adverse drug reaction reporting program

Area of Science:

• Pharmacovigilance
• Hospital Pharmacy Management
• Clinical Quality Improvement

Background:

• Adverse drug reactions (ADRs) pose a significant risk to patient safety.
• Effective ADR reporting systems are crucial for monitoring drug safety in healthcare settings.
• University hospitals require structured programs to manage and report ADRs.

Purpose of the Study:

• To describe the development and implementation of an adverse drug reaction (ADR) reporting program at a university hospital.
• To outline the critical steps and strategies employed in establishing a functional ADR reporting system.
• To evaluate the initial success and challenges of the newly developed ADR program.

Main Methods:

• Formation of a dedicated ADR subcommittee for program oversight.
• Definition of adverse drug reactions and criteria for reportable events.
• Development of a standardized ADR data collection form.
• Implementation of dual data collection methods: voluntary reporting and targeted drug monitoring.
• Promotion of the program through institutional communications.

Main Results:

• A consistent increase in reported ADR cases per quarter, rising from near zero to approximately 60.
• Successful establishment of an ADR subcommittee to manage the program.
• Implementation of both voluntary and targeted drug reporting approaches.
• Increased awareness and participation among healthcare professionals.

Conclusions:

• The developed ADR reporting program demonstrated success in increasing case identification and reporting.
• Key elements for successful ADR program development include clear definitions, dedicated personnel, and effective promotion.
• Continuous feedback and adaptation are essential for optimizing ADR surveillance in a hospital setting.